Építés alatt – nem éles oldal
Belépés
LeállítvaNo phase

Post-Discharge Pharmacist-led Rapid Medication Optimization for Heart Failure (Post-Discharge PHARM-HF)

Megadott ok: Slow recruitment

Key facts

Where
Vancouver, KanadaSee the site

Where in Kanada

  • St. Paul's HospitalVancouver, KanadaNo longer taking part

Trial details

Who runs it
University of British Columbia
Trial code
NCT06450522
Record updated
2025. február 25.
Original description
This study will recruit 100 patients from a post-discharge medicine clinic to test if the addition of a pharmacist to manage heart failure medications can increase appropriate use of these medications. Participants will be randomly assigned to usual care alone or with the addition of a pharmacist to help manage medications. They will be followed for 3 months by telephone/electronically-administered questionnaires, and 12 months using administrative health records. Outcome data will include information from patients on quality of life, treatment burden, medication adherence, as well as information from their medical record on heart failure events.Read full original descriptionShow less

Post-Discharge Pharmacist-led Rapid Medication Optimization for Heart Failure (Post-Discharge PHARM-HF): a Randomized Controlled Trial

This study will recruit 100 patients from a post-discharge medicine clinic to test if the addition of a pharmacist to manage heart failure medications can increase appropriate use of these medications. Participants will be randomly assigned to usual care alone or with the addition of a pharmacist to help manage medications. They will be followed for 3 months by telephone/electronically-administered questionnaires, and 12 months using administrative health records. Outcome data will include information from patients on quality of life, treatment burden, medication adherence, as well as information from their medical record on heart failure events.

Inclusion: Age ≥19 years; Attending their initial visit to the PDMC; Diagnosis of HF.

Exclusion: None.

ClinicalTrials.gov NCT06450522